Literature DB >> 27216142

Cellular thermal shift and clickable chemical probe assays for the determination of drug-target engagement in live cells.

Hua Xu1, Ariamala Gopalsamy, Erik C Hett, Shores Salter, Ann Aulabaugh, Robert E Kyne, Betsy Pierce, Lyn H Jones.   

Abstract

Proof of drug-target engagement in physiologically-relevant contexts is a key pillar of successful therapeutic target validation. We developed two orthogonal technologies, the cellular thermal shift assay (CETSA) and a covalent chemical probe reporter approach (harnessing sulfonyl fluoride tyrosine labeling and subsequent click chemistry) to measure the occupancy of the mRNA-decapping scavenger enzyme DcpS by a small molecule inhibitor in live cells. Enzyme affinity determined using isothermal dose response fingerprinting (ITDRFCETSA) and the concentration required to occupy 50% of the enzyme (OC50) using the chemical probe reporter assay were very similar. In this case, the chemical probe method worked well due to the long offset kinetics of the reversible inhibitor (determined using a fluorescent dye-tagged probe). This work suggests that CETSA could become the first choice assay to determine in-cell target engagement due to its simplicity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27216142     DOI: 10.1039/c6ob01078d

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  Quantitative measurement of intracellular HDAC1/2 drug occupancy using a trans-cyclooctene largazole thiol probe.

Authors:  Hua Xu; Lee R Roberts; Song Chou; Betsy Pierce; Arjun Narayanan; Lyn H Jones
Journal:  Medchemcomm       Date:  2017-01-09       Impact factor: 3.597

2.  Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.

Authors:  Takuji Yamauchi; Takeshi Masuda; Matthew C Canver; Michael Seiler; Yuichiro Semba; Mohammad Shboul; Mohammed Al-Raqad; Manami Maeda; Vivien A C Schoonenberg; Mitchel A Cole; Claudio Macias-Trevino; Yuichi Ishikawa; Qiuming Yao; Michitaka Nakano; Fumio Arai; Stuart H Orkin; Bruno Reversade; Silvia Buonamici; Luca Pinello; Koichi Akashi; Daniel E Bauer; Takahiro Maeda
Journal:  Cancer Cell       Date:  2018-02-22       Impact factor: 31.743

3.  In vitro and in vivo effects of 2,4 diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS: Context-specific modulation of SMN transcript levels.

Authors:  Jonathan J Cherry; Christine J DiDonato; Elliot J Androphy; Alessandro Calo; Kyle Potter; Sara K Custer; Sarah Du; Timothy L Foley; Ariamala Gopalsamy; Emily J Reedich; Susana M Gordo; William Gordon; Natalie Hosea; Lyn H Jones; Daniel K Krizay; Gregory LaRosa; Hongxia Li; Sachin Mathur; Carol A Menard; Paraj Patel; Rebeca Ramos-Zayas; Anne Rietz; Haojing Rong; Baohong Zhang; Michael A Tones
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.